Thanks for supplying GS estimates. My guess is that RBL blows past Q2 estimates. 3 Q EST looks woefully low. As previously discussed, either analysts will guide us to a higher SP or free market forces will come into play. RBL is still remarkably cheap compared to its global peers. I appreciate the new MD seems like a solid choice....but RBL multiple is just too cheap to stay independent.
- Forums
- ASX - By Stock
- ATG
- Strong Nov Sales - early sales guidance from SPT and MyDEAL + Kogan takeover MightyApe
Strong Nov Sales - early sales guidance from SPT and MyDEAL + Kogan takeover MightyApe, page-41
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATG (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
0.020(6.06%) |
Mkt cap ! $100.4M |
Open | High | Low | Value | Volume |
32.5¢ | 35.0¢ | 32.5¢ | $65.23K | 196.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2068 | 32.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 3999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2068 | 0.325 |
4 | 200438 | 0.320 |
3 | 37523 | 0.315 |
7 | 70285 | 0.310 |
1 | 485000 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 3999 | 1 |
0.365 | 32213 | 1 |
0.370 | 28960 | 2 |
0.380 | 42388 | 9 |
0.385 | 30000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
ATG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online